Bray GA - Search Results

1

Sibutramine produces dose-related weight loss.

Bray GA, Blackburn GL, Ferguson JM, Greenway FL, Jain AK, Mendel CM, Mendels J, Ryan DH, Schwartz SL, Scheinbaum ML, Seaton TB. Bray GA, et al. Obes Res. 1999 Mar;7(2):189-98. doi: 10.1002/j.1550-8528.1999.tb00701.x. Obes Res. 1999. PMID: 10102256 Free article. Clinical Trial.

2

A double-blind randomized placebo-controlled trial of sibutramine.

Bray GA, Ryan DH, Gordon D, Heidingsfelder S, Cerise F, Wilson K. Bray GA, et al. Obes Res. 1996 May;4(3):263-70. doi: 10.1002/j.1550-8528.1996.tb00544.x. Obes Res. 1996. PMID: 8732960 Free article. Clinical Trial.

3

Conference report--obesity: new directions, June 27-29, 1998, Charleston, South Carolina.

Ryan DH, Bray GA, Rössner S, Galasso GJ. Ryan DH, et al. Among authors: bray ga. Obes Res. 1999 May;7(3):303-8. doi: 10.1002/j.1550-8528.1999.tb00411.x. Obes Res. 1999. PMID: 10348503 Free article. No abstract available.

4

Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine.

Ryan DH, Bray GA, Helmcke F, Sander G, Volaufova J, Greenway F, Subramaniam P, Glancy DL. Ryan DH, et al. Among authors: bray ga. Obes Res. 1999 Jul;7(4):313-22. doi: 10.1002/j.1550-8528.1999.tb00414.x. Obes Res. 1999. PMID: 10440587 Free article.

5

Pharmaceutical cost savings of treating obesity with weight loss medications.

Greenway FL, Ryan DH, Bray GA, Rood JC, Tucker EW, Smith SR. Greenway FL, et al. Among authors: bray ga. Obes Res. 1999 Nov;7(6):523-31. doi: 10.1002/j.1550-8528.1999.tb00709.x. Obes Res. 1999. PMID: 10574509 Free article.

6

Methods to maximize retention in weight loss studies.

Greenway FL, Bray GA, Marlin RL. Greenway FL, et al. Among authors: bray ga. Obes Res. 1999 Nov;7(6):593-6. doi: 10.1002/j.1550-8528.1999.tb00719.x. Obes Res. 1999. PMID: 10574519 Free article. Clinical Trial.

7

Effect of diet composition on energy expenditure during weight loss: the POUNDS LOST Study.

Bray GA, Smith SR, DeJonge L, de Souza R, Rood J, Champagne CM, Laranjo N, Carey V, Obarzanek E, Loria CM, Anton SD, Ryan DH, Greenway FL, Williamson D, Sacks FM. Bray GA, et al. Int J Obes (Lond). 2012 Mar;36(3):448-55. doi: 10.1038/ijo.2011.173. Epub 2011 Sep 27. Int J Obes (Lond). 2012. PMID: 21946707 Free PMC article. Clinical Trial.

8

Sibutramine: a novel new agent for obesity treatment.

Ryan DH, Kaiser P, Bray GA. Ryan DH, et al. Among authors: bray ga. Obes Res. 1995 Nov;3 Suppl 4:553S-559S. doi: 10.1002/j.1550-8528.1995.tb00227.x. Obes Res. 1995. PMID: 8697058 Free article. Review.

9

Current and potential drugs for treatment of obesity.

Bray GA, Greenway FL. Bray GA, et al. Endocr Rev. 1999 Dec;20(6):805-75. doi: 10.1210/edrv.20.6.0383. Endocr Rev. 1999. PMID: 10605627 Review. No abstract available.

10

Common apolipoprotein A-IV variants are associated with differences in body mass index levels and percentage body fat.

Lefevre M, Lovejoy JC, DeFelice SM, Keener JW, Bray GA, Ryan DH, Hwang DH, Greenway FL. Lefevre M, et al. Among authors: bray ga. Int J Obes Relat Metab Disord. 2000 Aug;24(8):945-53. doi: 10.1038/sj.ijo.0801260. Int J Obes Relat Metab Disord. 2000. PMID: 10951531

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

924 results

Search Page